EVO — Evotec SE stock price, charts and financials

QT34Evotec SE

Evotec SE (NASDAQ: EVO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
1.95
+0.01+0.52%
OverviewShort InterestFilings
EVOQT34Evotec SE·NASDAQ
1.95+0.52%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 14, 20266-KForeign issuer report
Jun 30, 20266-KForeign issuer report
Jun 17, 20266-KForeign issuer report
May 06, 20266-KForeign issuer report
May 01, 2026SC 13D/ABeneficial ownership statement (active, amended)
Apr 30, 20266-KForeign issuer report
Apr 24, 20266-KForeign issuer report
Apr 08, 202620-FAnnual report (foreign issuers)
Apr 08, 20266-KForeign issuer report
Apr 07, 20266-KForeign issuer report
Apr 06, 2026SC 13D/ABeneficial ownership statement (active, amended)
Mar 30, 2026SC 13DBeneficial ownership statement (active)
Mar 10, 20266-KForeign issuer report
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 16, 20266-KForeign issuer report
Jan 16, 2026SC 13GBeneficial ownership statement (passive)
Jan 13, 20266-KForeign issuer report
Jan 08, 20266-KForeign issuer report
Jan 06, 20266-KForeign issuer report
Jan 02, 20266-KForeign issuer report
Jan 02, 20266-KForeign issuer report
Dec 08, 20256-KForeign issuer report
Nov 14, 2025SC 13G/ABeneficial ownership statement (passive, amended)
Nov 06, 20256-KForeign issuer report
Nov 05, 20256-KForeign issuer report
#1 / 25 of 116
Page
▼
/ 5